A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

NCT06123338 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Gastric Adenocarcinoma
HER2 Gene Mutation

Interventions

DRUG: Pembrolizumab
DRUG: Trastuzumab
DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: 5-Fluorouracil
DRUG: Docetaxel

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]